title: Highlights in Central Nervous System Tumors.
authors.affiliation: Neurology Clinic and National Center for Tumor Disease, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.
authors.forename: Anne
authors.initials: A
authors.lastname: Hertenstein
authors.affiliation: Neurology Clinic and National Center for Tumor Disease, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Platten
authors.affiliation: Neurology Clinic and National Center for Tumor Disease, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Wick
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018572:Disease-Free Survival; D005260:Female; D005910:Glioma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D008297:Male; D000077204:Temozolomide
chemical_list: D003606:Dacarbazine; D000077204:Temozolomide